With growth in revenue of 7% when measured in local currencies in Q1 2009/10,
Ambu is winning market share and developments remain positive for the company.
The operating profit, EBIT, for Q1 was DKK 18.7m against DKK 15.3m for the same
period last year, up 22%. The EBIT margin was 9% against 7% for the same period
last year. Ambu achieved significantly higher growth than the estimated general
market growth in Europe of 3-5%. In the USA where market growth stood at 1-3%,
revenue increased by 11% when measured in the local currency. The outlook for
2009/10 (before special items relating to the pending patent cases) remains of
revenue of approx. DKK 900-925m and an EBIT margin of 12-12.5%.
